DOJ charges 455 in $6.5B health fraud sweep
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- DOJ charged 455 people in a sweep alleging $6.5 billion in false health care claims, with cases charged or unsealed since June 8link ›
- Jason Finkelstein, 53, allegedly signed off on 63 cardiac images in 11 seconds without reviewing them; the patient's enlarged heart was missed and the teenager later died on a basketball courtlink ›
- Finkelstein's company allegedly billed insurers $89 million across 48 states from 2019 through late 2024 using uncredentialed sonographers and fabricated hypertension diagnoseslink ›
- Other targets include a Texas nurse accused of billing Medicaid for unnecessary wound care and a hospice owner accused of paying a funeral home employee kickbacks for Medicare beneficiary datalink ›
- NIH scientists Vincent Munster and Claude Kwe pleaded not guilty in Missoula on June 3 to smuggling 113 sealed vials through Detroit airport on January 25, claiming the case held 'diagnostic and testing equipment'link ›
- The House Energy and Commerce Committee sent NIH Director Jay Bhattacharya a June 16 letter seeking records on Rocky Mountain Labs' biosafety, citing two prior CCHF exposures including one from a monkey bitelink ›
- Minicircle plans to launch an unapproved injectable klotho gene therapy at clinics in Honduras, the Bahamas, and Panama within six months, requiring no FDA approval and with no published trial datalink ›
Federal prosecutors charged 455 defendants with $6.5 billion in false health care claims in a two-week sweep, but the case that defines the crackdown is Florida cardiologist Jason Finkelstein's: he allegedly signed off on 63 cardiac images in 11 seconds for a teenager who later died on a basketball court, while billing insurers $89 million across 48 states. His warning to a co-conspirator — 'one of them drops dead on a field, they're coming after both of us' — is the line prosecutors will hang the case on. The same week, two NIH scientists at Montana's BSL-4 Rocky Mountain Labs pleaded not guilty to smuggling 113 vials of mpox through Detroit, evidence that the federal health system is now under simultaneous fire from fraudsters and from its own.
The stories behind this week
Justice Department announces hundreds of charges in multibillion-dollar health care fraud crackdownThe Finkelstein case reframes health care fraud from a paper crime into a patient-harm story: prosecutors say a teenager died because a licensed cardiologist allegedly rubber-stamped cardiac results in 11 seconds without reading them, all while billing insurers $89 million. With 455 defendants and $6.5 billion in alleged false claims, the sweep signals the DOJ's intent — backed by McDonald's new AAG role — to pursue fraud prosecutions that target both financial loss and clinical negligence.
Two NIH scientists charged with smuggling mpox into USThe congressional probe targets a BSL-4 facility — the highest biocontainment tier — that has already logged two confirmed employee exposures to a potentially fatal hemorrhagic fever virus. With both scientists out on bail and up to five years of prison time on the line, the case gives Congress leverage to reshape federal oversight of how dangerous pathogens are transported and declared at the border.
Phages Hijack Vaccine Immunity to Kill Mouse TumorsIf human trials succeed, this approach offers a systemically administered immunotherapy that piggybacks on routine vaccinations — potentially reaching metastatic tumors that current oncolytic viruses can't access because they require direct injection. For the large share of cancer patients who don't respond to existing immunotherapies, redirecting pre-existing immune memory toward tumors would represent a new treatment class built on a delivery mechanism that is already regulator-approved in vaccine contexts.
UCR philosophers: consciousness need not be Earth-likeBy reframing consciousness as a substrate-flexible property rather than a biological accident, the paper shifts a question usually confined to neuroscience labs into a cosmic frame — weakening the default dismissal of non-Earth-like minds and, by extension, making it philosophically harder to rule out silicon-based AI consciousness on biological grounds alone.
Opinion: How I used public radio to recruit 20,000 participants for a peer-reviewed study on walking breaksThe study shows mass public participation in real-world health research is viable when a media outlet partners with an academic institution: 20,000 Americans sustained a movement intervention, and self-reported fatigue dropped 25%. With U.S. healthcare spending rolling toward $5 trillion a year, the author argues the underused resource is ordinary people willing to volunteer for non-invasive, citizen-led science.
Why some brains defy stroke — and drugs to help theOnly about 35% of stroke survivors make a full or near-full recovery, leaving roughly 100 million people globally with disabling after-effects including aphasia and paralysis. The therapies now in animal or early human studies — a repurposed HIV drug, a gamma-boosting compound, DMT, psilocybin and a brain-computer interface — could convert what is currently a luck-of-the-draw recovery into a treatable one, though none has yet passed human efficacy trials.
Minicircle sells unapproved klotho gene therapyA single adverse event from Minicircle's 24-person, uncontrolled trial could derail the entire legitimate klotho research field, warns Alex John London of Carnegie Mellon. With gene-therapy effects lasting up to a year, unknown long-term risks loom — and patients paying for offshore treatments effectively become trial subjects without the safeguards regulators exist to provide.
Ebola and Hantavirus Mimic Flu Before Turning DeadlyFrontline clinicians need to distinguish routine influenza from hantavirus or Ebola in early stages, especially since the Andes virus strain can transmit between people and Bundibugyo ebolavirus—currently killing up to half of those infected—has no approved vaccine or treatment, unlike the Zaire strain.
Why it matters: If Finkelstein's 11-second timestamp holds up in court, every high-volume cardiac screening outfit in the country is now legally exposed — that log data is the kind of paper trail most fraud defendants never hand prosecutors voluntarily.
Ask SkimNews
